Credit Suisse’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1
| Closed | -$7 | – | 3502 |
|
|
2022
Q4 | $7 | Sell |
1
-136
| -99% | -$952 | ﹤0.01% | 3763 |
|
|
2022
Q3 | $2K | Buy |
137
+113
| +471% | +$1.65K | ﹤0.01% | 3718 |
|
|
2022
Q2 | $0 | Buy |
+24
| New | – | ﹤0.01% | 4110 |
|
|
2016
Q3 | – | Sell |
-2,015
| Closed | -$18K | – | 3794 |
|
|
2016
Q2 | $18K | Buy |
+2,015
| New | +$18K | ﹤0.01% | 3866 |
|